Cleared Special

K232574 - VASSALLO GT Crossing14 (FDA 510(k) Clearance)

Oct 2023
Decision
47d
Days
Class 2
Risk

K232574 is an FDA 510(k) clearance for the VASSALLO GT Crossing14. This device is classified as a Wire, Guide, Catheter (Class II - Special Controls, product code DQX).

Submitted by Filmec Co. , Ltd. (Hagoya-Shi, JP). The FDA issued a Cleared decision on October 11, 2023, 47 days after receiving the submission on August 25, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1330.

Submission Details

510(k) Number K232574 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 2023
Decision Date October 11, 2023
Days to Decision 47 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQX - Wire, Guide, Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1330

Similar Devices - DQX Wire, Guide, Catheter

All 27
FMD Peripheral Guide Wire F-14 Flex 6
K260544 · FMD Co., Ltd. · Mar 2026
Enroute 0.014'' Transcarotid Guidewire
K253746 · Lake Region Medical · Mar 2026
EmeryGlide™ (EG18008901)
K253262 · Nano4imaging GmbH · Mar 2026
Splashwire Hydrophilic Guide Wire (MSWSTD35150J3)
K253847 · Merit Medical Ireland, Ltd. · Jan 2026
InQwire Super Stiff Guide Wire (IQSS32180J3)
K251385 · Merit Medical Ireland, Ltd. · Jan 2026
Solo Pace Fusion System (SOLOFUSE1)
K252674 · Solo Pace, Inc. · Jan 2026